| Syncom Formulations (India) Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524470 |
NSE Symbol : SYNCOMF |
P/E(TTM) : 17.16 |
|
ISIN Demat : INE312C01025 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.81 |
|
Book Value(₹) : 4.39 |
Market Cap(₹Cr) : 1,306.60 |
Face Value(₹) : 1.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 134.00 | 114.59 | 121.44 | 116.55 | 148.46 | 127.03 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 134.00 | 114.59 | 121.44 | 116.55 | 148.46 | 127.03 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 14.23 | 5.48 | 5.23 | 6.06 | 6.91 | 3.82 |
| Total Income | 148.23 | 120.07 | 126.67 | 122.61 | 155.37 | 130.85 |
| Total Expenditure | 112.52 | 93.42 | 102.71 | 100.77 | 130.99 | 112.43 |
| PBIDT | 35.71 | 26.66 | 23.96 | 21.84 | 24.38 | 18.42 |
| Interest | 0.37 | 0.25 | 0.25 | 0.24 | 0.09 | 0.21 |
| PBDT | 35.34 | 26.41 | 23.71 | 21.60 | 24.29 | 18.21 |
| Depreciation | 2.48 | 1.36 | 1.35 | 1.34 | 1.29 | 1.31 |
| Tax | 7.17 | 6.00 | 5.22 | 4.32 | 4.50 | 4.03 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.12 | 0.18 | 0.30 | 0.21 | 1.00 | 0.09 |
| Reported Profit After Tax | 24.57 | 18.86 | 16.84 | 15.73 | 17.50 | 12.79 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.03 | 0.01 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 24.57 | 18.86 | 16.84 | 15.70 | 17.49 | 12.79 |
| EPS (Unit Curr.) | 0.26 | 0.20 | 0.18 | 0.21 | 0.19 | 0.14 |
| EPS (Adj) (Unit Curr.) | 0.26 | 0.20 | 0.18 | 0.21 | 0.19 | 0.14 |
| Calculated EPS (Unit Curr.) | 0.26 | 0.20 | 0.18 | 0.17 | 0.19 | 0.14 |
| Calculated EPS (Adj) (Unit Curr.) | 0.26 | 0.20 | 0.18 | 0.17 | 0.19 | 0.14 |
| Calculated EPS (Ann.) (Unit Curr.) | 1.05 | 0.80 | 0.72 | 0.67 | 0.74 | 0.54 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 1.05 | 0.80 | 0.72 | 0.67 | 0.74 | 0.54 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 94.00 | 94.00 | 94.00 | 94.00 | 94.00 | 94.00 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 26.65 | 23.27 | 19.73 | 18.74 | 16.42 | 14.50 |
| PBDTM(%) | 26.37 | 23.05 | 19.52 | 18.53 | 16.36 | 14.34 |
| PATM(%) | 18.34 | 16.46 | 13.87 | 13.50 | 11.79 | 10.07 |
